{"artifact":{"id":"open_question-3ea623a1-ab86-451a-9ddc-ba240648a4fa","artifact_type":"open_question","entity_ids":"[\"mechanisms\"]","title":"Therapeutic window**: Is there a safe level of MARK inhibition?","quality_score":0.5,"created_by":"backfill_open_questions","provenance_chain":"[]","content_hash":"f4b82de6b958ee1a3a7e6bd9adb05ab90bb4c08191aefbb72ba7217c47dd8a76","metadata":{"status":"open","_origin":{"url":null,"type":"internal","tracked_at":"2026-04-26T03:29:33.008087"},"field_tag":"mechanisms","source_id":"mechanisms-mark-tau-phosphorylation-pathway","sub_field":"mark-tau-phosphorylation-pathway","source_kind":"wiki","question_hash":"1845f9adfeea14789e56ad30bd7183b5bdbdf95e0eb2ce59a5771c05b16479d2","question_text":"Therapeutic window**: Is there a safe level of MARK inhibition?","importance_elo":1500,"_schema_version":1,"evidence_summary":"Extracted from wiki page mechanisms-mark-tau-phosphorylation-pathway","evidence_xref_at":"2026-04-27T13:52:10.049390+00:00","tractability_score":0.5,"potential_impact_score":0.5},"created_at":"2026-04-25T20:29:33.008306-07:00","updated_at":"2026-04-25T20:29:33.008306-07:00","version_number":4,"parent_version_id":null,"version_tag":null,"changelog":null,"is_latest":1,"lifecycle_state":"active","superseded_by":null,"deprecated_at":null,"deprecated_reason":null,"dependencies":null,"market_price":0.5,"origin_type":"internal","origin_url":null,"lifecycle_changed_at":"2026-04-25T20:29:33.008306-07:00","citation_count":0,"embed_count":0,"derivation_count":0,"support_count":0,"contradiction_count":0,"total_usage":0.0,"usage_score":0.5,"usage_computed_at":null,"quality_status":null,"contributors":[],"answers_question_ids":null,"deprecated_reason_detail":null,"deprecated_reason_code":null,"commit_sha":null,"commit_submodule":null,"last_mutated_at":"2026-05-16T14:51:34.657673-07:00","disputed_at":null,"gap_id":null,"mission_id":null,"intrinsic_priority":null,"effective_priority":null,"artifact_id":"a356343a-98e6-49a9-87c8-64cf388f1e70","artifact_dir":null,"primary_filename":null,"accessory_filenames":null,"folder_layout_version":1,"migrated_to_folder_at":null,"hypothesis_id":null,"authorship":{"kind":"human","contributors":[{"role":"author","actor_ref":"backfill_open_questions"}]},"epistemic_tier":"T3_provisional","created_by_agent_id":null},"outgoing_links":[{"target_artifact_id":"wiki-mechanisms-mark-tau-phosphorylation-pathway","link_type":"derives_from","strength":0.9,"evidence":"{\"method\": \"open_question_wiki_crosslink\", \"cycle\": \"artifact-enrichment-2026-04-27\"}"},{"target_artifact_id":"hypothesis-h-0f00fd75","link_type":"bears_on_question","strength":0.4,"evidence":"{\"confidence\": 0.4, \"judge_persona\": \"domain-expert\", \"model\": \"all-MiniLM-L6-v2\"}"},{"target_artifact_id":"experiment-exp-wiki-experiments-anti-tau-therapy-failure-psp","link_type":"partial_answer_for","strength":0.45,"evidence":"{\"confidence\": 0.45, \"judge_persona\": \"domain-expert\", \"model\": \"all-MiniLM-L6-v2\"}"},{"target_artifact_id":"experiment-exp-wiki-experiments-tau-propagation-causality","link_type":"partial_answer_for","strength":0.48,"evidence":"{\"confidence\": 0.48, \"judge_persona\": \"domain-expert\", \"model\": \"all-MiniLM-L6-v2\"}"},{"target_artifact_id":"experiment_proposal-9722b9f2-f1ce-4c29-bd64-1ab2d3208967","link_type":"discriminating_experiment","strength":0.42,"evidence":"{\"confidence\": 0.42, \"judge_persona\": \"domain-expert\", \"model\": \"all-MiniLM-L6-v2\"}"},{"target_artifact_id":"experiment-exp-6b555d09-fc9c-4209-a344-84301cc2ab55","link_type":"partial_answer_for","strength":0.55,"evidence":"{\"confidence\": 0.55, \"judge_persona\": \"domain-expert\", \"model\": \"all-MiniLM-L6-v2\"}"}],"incoming_links":[],"current_artifact_id":"open_question-3ea623a1-ab86-451a-9ddc-ba240648a4fa","is_canonical":true,"supersede_chain":["open_question-3ea623a1-ab86-451a-9ddc-ba240648a4fa"]}